NCT06299189

Brief Summary

The primary objective of this study is to explore and evaluate the use and utility of a guided Internet-delivered psychological treatment for adults with ADHD with a combined focus on: i) Evaluating the impact of potential predictors to treatment adherence, treatment response, treatment use and utilty. ii) Evaluating the feasibility, clinical benefits and implementation process of the treatment in routine outpatient care. iii) Evaluate the cost-effectiveness of the treatment program.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
16mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Jan 2024Sep 2027

Study Start

First participant enrolled

January 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 28, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 7, 2024

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

August 26, 2025

Status Verified

August 1, 2025

Enrollment Period

3.7 years

First QC Date

February 28, 2024

Last Update Submit

August 25, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • The Adult ADHD Self-Rating Scale

    Measure of ADHD symptom severity

    From enrollment to the end of 6-months follow-up

  • Adult ADHD Quality of Life Measure

    Measure of impact of ADHD on quality of life

    From enrollment til the end of 6-month follow-up.

Secondary Outcomes (4)

  • The Patient Health Questionnaire

    From enrollment til the end of 6-month follow-up.

  • Generalized Anxiety Disorder-7

    From enrollment til the end of 6-month follow-up.

  • Personality Disorder Severity ICD-11

    From enrollment til the end of 6-month follow-up.

  • EuroQoL 5D-5L

    From enrollment to end of 6-month follow-up.

Study Arms (1)

A self-guided internet delivered intervention

EXPERIMENTAL

MinADHD: 7 self-help modules Interventions: Behavioural

Behavioral: MinADHD

Interventions

MinADHDBEHAVIORAL

Guided self-help, 7 modules Interventions

A self-guided internet delivered intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18
  • A self-reported diagnosis of ADHD
  • Access to and ability to use a computer, smartphone and the Internet.
  • Speaks, writes and reads Norwegian

You may not qualify if:

  • In need of other psychological treatment for mental health illness such as borderline or personality disorder, bipolar disorder, substance abuse or psychosis.
  • Ongoing psychological treatment for ADHD or other psychiatric illnesses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bjørgvin DPS

Bergen, Norway

RECRUITING

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2024

First Posted

March 7, 2024

Study Start

January 1, 2024

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

August 26, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

The IPD collected for the current trial is considered sensitive patient information.

Locations